Jasleen K Jolly1, Markus Groppe2, Jacqueline Birks3, Susan M Downes4, Robert E MacLaren2. 1. Nuffield Laboratory of Ophthalmology, University of Oxford, Oxford, United Kingdom; Oxford Biomedical Research Centre and Moorfields Eye Hospital-UCL Institute of Ophthalmology NIHR Biomedical Research Centre, London, United Kingdom. Electronic address: enquiries@eye.ox.ac.uk. 2. Nuffield Laboratory of Ophthalmology, University of Oxford, Oxford, United Kingdom; Oxford Biomedical Research Centre and Moorfields Eye Hospital-UCL Institute of Ophthalmology NIHR Biomedical Research Centre, London, United Kingdom. 3. Centre For Statistics In Medicine, University of Oxford, Oxford, United Kingdom. 4. Nuffield Laboratory of Ophthalmology, University of Oxford, Oxford, United Kingdom.
Abstract
PURPOSE: To characterize defects in color vision in patients with choroideremia. DESIGN: Prospective cohort study. METHODS: Thirty patients with choroideremia (41 eyes) and 10 age-matched male controls (19 eyes) with visual acuity of ≥6/36 attending outpatient clinics in Oxford Eye Hospital underwent color vision testing with the Farnsworth-Munsell 100 hue test, visual acuity testing, and autofluorescence imaging. To exclude changes caused by degeneration of the fovea, a subgroup of 14 patients with a visual acuity ≥6/6 was analyzed. Calculated color vision total error scores were compared between the groups and related to a range of factors using a random-effects model. RESULTS: Mean color vision total error scores were 120 (95% confidence interval [CI] 92, 156) in the ≥6/6 choroideremia group, 206 (95% CI 161, 266) in the <6/6 visual acuity choroideremia group, and 47 (95% CI 32, 69) in the control group. Covariate analysis showed a significant difference in color vision total error score between the groups (P < .001 between each group). CONCLUSIONS: Patients with choroideremia have a functional defect in color vision compared with age-matched controls. The color vision defect deteriorates as the degeneration encroaches on the fovea. The presence of an early functional defect in color vision provides a useful biomarker against which to assess successful gene transfer in gene therapy trials.
PURPOSE: To characterize defects in color vision in patients with choroideremia. DESIGN: Prospective cohort study. METHODS: Thirty patients with choroideremia (41 eyes) and 10 age-matched male controls (19 eyes) with visual acuity of ≥6/36 attending outpatient clinics in Oxford Eye Hospital underwent color vision testing with the Farnsworth-Munsell 100 hue test, visual acuity testing, and autofluorescence imaging. To exclude changes caused by degeneration of the fovea, a subgroup of 14 patients with a visual acuity ≥6/6 was analyzed. Calculated color vision total error scores were compared between the groups and related to a range of factors using a random-effects model. RESULTS: Mean color vision total error scores were 120 (95% confidence interval [CI] 92, 156) in the ≥6/6 choroideremia group, 206 (95% CI 161, 266) in the <6/6 visual acuity choroideremia group, and 47 (95% CI 32, 69) in the control group. Covariate analysis showed a significant difference in color vision total error score between the groups (P < .001 between each group). CONCLUSIONS: Patients with choroideremia have a functional defect in color vision compared with age-matched controls. The color vision defect deteriorates as the degeneration encroaches on the fovea. The presence of an early functional defect in color vision provides a useful biomarker against which to assess successful gene transfer in gene therapy trials.
Authors: Immanuel P Seitz; Jasleen K Jolly; M Dominik Fischer; Matthew P Simunovic Journal: Graefes Arch Clin Exp Ophthalmol Date: 2018-02-05 Impact factor: 3.117
Authors: Tomas S Aleman; Grace Han; Leona W Serrano; Nicole M Fuerst; Emily S Charlson; Denise J Pearson; Daniel C Chung; Anastasia Traband; Wei Pan; Gui-Shuang Ying; Jean Bennett; Albert M Maguire; Jessica I W Morgan Journal: Ophthalmology Date: 2016-12-13 Impact factor: 12.079
Authors: Liangbo L Shen; Aneesha Ahluwalia; Mengyuan Sun; Benjamin K Young; Holly K Grossetta Nardini; Lucian V Del Priore Journal: Br J Ophthalmol Date: 2020-05-29 Impact factor: 5.908
Authors: Ahmed M Hagag; Andreas Mitsios; Akshay Narayan; Alessandro Abbouda; Andrew R Webster; Adam M Dubis; Mariya Moosajee Journal: Eye (Lond) Date: 2020-05-28 Impact factor: 3.775